N-demethylation of the antineoplastic agent hexamethylmelamine by rats and man
- PMID: 4748436
N-demethylation of the antineoplastic agent hexamethylmelamine by rats and man
Similar articles
-
Metabolism of hexamethylmelamine-ring-14C in rats and man.Cancer Res. 1974 Oct;34(10):2669-74. Cancer Res. 1974. PMID: 4414651 No abstract available.
-
Absorption, tissue distribution, and excretion of the anti-neoplastic agent guanazole in the rat.Res Commun Chem Pathol Pharmacol. 1974 Mar;7(3):497-512. Res Commun Chem Pathol Pharmacol. 1974. PMID: 4824824 No abstract available.
-
The metabolism of tamoxifen (I.C.I. 46,474). I. In laboratory animals.Xenobiotica. 1973 Nov;3(11):693-709. doi: 10.3109/00498257309151594. Xenobiotica. 1973. PMID: 4361333 No abstract available.
-
[Pharmacokinetic studies on 14C-azapropazone dihydrate in the rat].Arzneimittelforschung. 1973 Jul;23(7):913-9. Arzneimittelforschung. 1973. PMID: 4800443 German. No abstract available.
-
Metabolism of triazine anticancer agents.Pharmacol Ther. 1987;35(3):291-300. doi: 10.1016/0163-7258(87)90098-2. Pharmacol Ther. 1987. PMID: 3324116 Review. No abstract available.
Cited by
-
Pharmacokinetics and metabolism of hexamethylmelamine in mice after IP administration.Cancer Chemother Pharmacol. 1986;18(3):226-30. doi: 10.1007/BF00273391. Cancer Chemother Pharmacol. 1986. PMID: 3100080
-
Preclinical toxicology, pharmacokinetics and formulation of N2,N4,N6-trihydroxymethyl-N2,N4,N6-trimethylmelamine (trimelamol), a water-soluble cytotoxic s-triazine which does not require metabolic activation.Cancer Chemother Pharmacol. 1986;17(3):251-8. doi: 10.1007/BF00256694. Cancer Chemother Pharmacol. 1986. PMID: 3091280
-
Clinical pharmacokinetics of altretamine.Clin Pharmacokinet. 1995 Jun;28(6):439-48. doi: 10.2165/00003088-199528060-00002. Clin Pharmacokinet. 1995. PMID: 7656502 Review.
-
Pharmacologic studies of anticancer drugs with the human tumor stem cell assay.Cancer Chemother Pharmacol. 1981;6(3):253-64. doi: 10.1007/BF00256978. Cancer Chemother Pharmacol. 1981. PMID: 7318146
-
N-methyl antitumour agents. A distinct class of anticancer drugs?Cancer Chemother Pharmacol. 1987;19(2):91-102. doi: 10.1007/BF00254559. Cancer Chemother Pharmacol. 1987. PMID: 3552281 Review.